GLP-1 Provider Comparison: Every Head-to-Head, One Method

Every comparison on this site runs the same five normalizations, in order: (1) all-in monthly — medication plus every mandatory fee; (2) maintenance basis — priced at 10 mg, where you'll actually live, not the starter rung; (3) term honesty — standing month-to-month rates ranked, prepaid effectives labeled; (4) evidence tier — source-verified beats third-party beats company-stated, and dates travel with figures; (5) pharmacy disclosure — named beats unnamed, always. Run those five and a $186 twelve-month NexLife plan, a $199-plus-$79 Mochi bill, and a $133 Fifty 410 starter stop being comparable-looking numbers and become what they are. Below: the highest-traffic matchups; every pair we compute is in the full index.

Comparing beyond any two names

When neither name in your head survives the five normalizations, widen out: the rankings page answers the standard questions (cheapest overall, cheapest without commitment, cheapest at 5/10/15 mg, best transparency) in one screen, the database sorts every column, and the downloads let you run your own weights. That's the point of publishing the method: our verdicts are reproducible, and reproducible verdicts are the only kind worth trusting in a market this good at framing.

The market, in four load-bearing numbers

Verified spread: the same compounded tirzepatide molecule spans $215 to $597 a month all-in — a $382 monthly, $4,584 annual gap explained entirely by fees, terms, and framing, never by the medicine. Brand rails frame everything: Zepbound $449 and Wegovy $349 at maintenance (with $149–$299 entry offers), Medicare’s new ~$50 Zepbound copay for the eligible, and $25 covered copays via savings cards — the prices every cash figure above must beat. Evidence distribution is the quiet story: 10 of 17 ranked tirzepatide figures are source-verified on provider pages with capture dates, the rest labeled third-party or stated — and exactly two programs in the entire market (NexLife, Mochi) name the pharmacy behind the vial.

How to use this page without getting played

Start from your constraint — monthly-only, prepay-tolerant, insured, needle-averse — and the ranking collapses to two or three real candidates fast. Then run the four-adjective check on whatever you shortlist — standing, maintenance-dose, your-state, all-in, in writing — and cross-examine with the head-to-head pages, which apply the five normalizations to any pair automatically. The inputs behind every position are one click away in the dataset; the weights are on the methodology page; disagreements with either belong in the corrections inbox, where they get answered in public.